Table 2.
Gene Name | Expression Mode | Artemisinin (mg/g DW) | Fold Change | Reference | |
---|---|---|---|---|---|
Control | Transgenic | ||||
MVA or MEP pathway key genes | |||||
CrHMGR 1 | Overexpression | 0.32 | 0.39 | 1.22 | [52] |
0.37 | 0.60 | 1.62 | [35] | ||
CrDXR 1 | Overexpression | 0.52 | 1.21 | 2.33 | [36] |
IPPI1 | Overexpression | 0.75 | 2.5 | 3.33 | [38] |
HDR1 | Overexpression | 0.05 | 0.09 | 1.8 | [37] |
HDR1 | Down-regulation | 0.05 | 0.03 | 0.6 | |
GaFPPS 2 | Overexpression | 3 | 10.08 | 3.36 | [42] |
FPPS | Overexpression | 6.5 | 0.9 | 1.38 | [40] |
5.3 | 13.3 | 2.5 | [41] | ||
Artemisinin biosynthesis pathway key genes | |||||
ADS | Overexpression | 0.6 | 1.2 | 2 | [45] |
DBR2 | Overexpression | 0.94 | 2.14 | 2.26 | [46] |
8 | 22.6 | 2.83 | [53] | ||
ALDH1 | Overexpression | 8 | 25.6 | 3.2 | [54] |
HMGR, FPPS | Overexpression | 5 | 9 | 1.8 | [55] |
HMGR, ADS | Overexpression | 0.2 | 1.73 | 8.65 | [47] |
ADS-FPPS fusion | Overexpression | 10 | 26 | 2.6 | [48] |
CYP71AV1, CPR | Overexpression | 0.91 | 2.44 | 2.68 | [36] |
0.71 (mg/g FW) |
0.98 (mg/g FW) |
1.38 | [49] | ||
FPPS, CYP71AV1, CPR | Overexpression | 0.83 (mg/g FW) |
2.98 (mg/g FW) |
3.6 | [50] |
ADS, CYP71AV1, CPR | Overexpression | 6.4 | 15.1 | 2.4 | [56] |
ADS, CYP71AV1, CPR, ALDH1 | Overexpression | 8 | 27 | 3.4 | [51] |
Competitive pathway key genes | |||||
SQS | Down-regulation | 10 | 31.4 | 3.14 | [57] |
CPS | Down-regulation | 2.32 | 3.6 | 1.55 | [58] |
CPS | Down-regulation | 6.26 | 11.08 | 1.77 | [59] |
BFS | Down-regulation | 6.26 | 11.08 | 1.77 | |
GAS | Down-regulation | 6.26 | 12.71 | 2.03 | |
SQS | Down-regulation | 6.26 | 10.70 | 1.71 |
1CrHMGR and CrDXR genes were from C. roseus. 2 GaFPPS gene was from Gossypium arboreum.